China Medicine (CHME) Short Interest Ratio & Short Volume

Short interest is the volume of China Medicine shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 83,300 shares of CHME short. Learn More on China Medicine's current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling CHME is an investing strategy that aims to generate trading profit from China Medicine as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHME, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHME, twice per month. The most recent reporting period available is October, 31 2022.